Why Patients Switch Between GLP-1 Weight Loss Treatments
Compare Mounjaro and Wegovy: Key Switching Considerations
When you compare Mounjaro and Wegovy, the most significant difference lies in their mechanisms of action. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 receptors exclusively. This distinction affects how each medication works in your body and may influence side effect profiles. Many patients switch between these treatments based on individual response, tolerability, or cost considerations. The decision to compare Mounjaro and Wegovy often stems from seeking better value for money or addressing specific side effects experienced with their current treatment.
Both medications require prescription and clinical assessment, but switching doesn't mean starting from scratch. Your prescriber can determine appropriate dose equivalents when transitioning between treatments. At EverydayMeds, we've supported hundreds of patients through this transition process, ensuring continuity of care and optimal outcomes. The key is working with experienced prescribers who understand the nuances of GLP-1 therapy and can guide your switch safely.
Wegovy vs Mounjaro Pricing: Potential Monthly Savings
Cost comparison reveals significant potential savings when switching to Wegovy. Our maintenance dose (2.4mg) costs £209.99, whilst Mounjaro's equivalent doses typically range £30-50 higher monthly. New customers can apply code FIRST40 at checkout, whilst returning patients use code DOSE25 for additional savings. These codes are built into our pricing structure to ensure transparent, competitive costs for long-term weight management therapy.
Our bundle options provide added convenience and supply security. The Ultimate Stability Trio (three 2.4mg pens) offers three months of maintenance therapy for £649.99, perfect for patients established on their target dose. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99 for new patients beginning dose escalation. These bundles eliminate the need for monthly reordering whilst ensuring temperature-controlled delivery and Reliable Supply continuity.
Clinical Evidence When You Compare Mounjaro and Wegovy
In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across diverse patient populations, with the SELECT trial showing a 20% reduction in major cardiovascular events. However, when you compare Mounjaro and Wegovy trial data, direct comparisons aren't appropriate due to different study designs and patient populations.
Both medications have been rigorously tested and MHRA-approved for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. NICE guidance (TA875) recommends Wegovy with specialist weight management support, reflecting its evidence base and clinical utility. Individual response varies, which is why some patients benefit from switching between treatments under prescriber guidance.
How Wegovy Works in Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. It works primarily on brain appetite centres, reducing hunger signals and promoting satiety after smaller meals. This mechanism may help reduce food cravings and support portion control when combined with a reduced-calorie diet and increased physical activity. The once-weekly injection provides consistent medication levels, supporting steady appetite regulation throughout your treatment journey. Unlike some weight management approaches, Wegovy targets the biological pathways that regulate appetite, making it easier to maintain dietary changes long-term.
EverydayMeds Ordering Process for Treatment Switching
Switching treatments through EverydayMeds is straightforward and secure. Our 3-minute online clinical assessment captures your current treatment history, including previous GLP-1 experience and reasons for switching. This information helps our prescribers determine appropriate starting doses and identify any special considerations for your transition. Standard prescriber review takes 3 working days, with express 24-hour review available for urgent switches. Once approved, we dispatch your medication via next-day cold-chain delivery, ensuring temperature integrity from our GPhC-registered pharmacy (#9012878) to your door.
Storage and Practical Advantages of Wegovy
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, versus Mounjaro's 21-day limit. This advantage is particularly valuable for travel or busy lifestyles where consistent refrigeration isn't assured. The FlexTouch pen design provides intuitive dosing with clear dose indicators and reliable injection mechanisms. Wegovy follows a structured dose escalation schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance (week 17+), allowing gradual tolerance development and side effect minimisation.
Compare Mounjaro and Wegovy: Switching Protocol and Safety
Safe switching between GLP-1 treatments requires careful dose conversion and monitoring. When patients compare Mounjaro and Wegovy for switching purposes, timing and dose equivalency are crucial considerations. Most prescribers recommend starting Wegovy at an appropriate equivalent dose rather than returning to the initial 0.25mg dose, though this depends on individual circumstances and time since last injection. The transition typically involves a washout period consideration, as both medications have different half-lives and duration of action.
Our clinical team provides personalised switching protocols based on your current dose, treatment duration, and individual response patterns. We coordinate with your prescriber to ensure smooth transitions without treatment gaps that could affect your weight management progress. This professional oversight is essential when you compare Mounjaro and Wegovy switching options, as improper transitions can lead to side effect resurgence or treatment interruption.
Start Your Treatment Switch with EverydayMeds Today
Ready to explore switching from Mounjaro to Wegovy? Our clinical team is standing by to support your transition with expert guidance and competitive pricing. Use code FIRST40 (new customers) or DOSE25 (returning customers) at checkout for our best available pricing. Our comprehensive service includes pre-switch consultation, dose conversion guidance, and ongoing support throughout your treatment journey. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today. With our GPhC-registered service (#9012878) and temperature-controlled delivery, you can switch treatments confidently knowing you're receiving genuine, properly stored medication with professional clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
